Q1 2025 Management View President and CEO Kim Scott highlighted that Q1 2025 revenue was $684 million, consistent with Q4 2024, while adjusted EBITDA reached $81.2 million, a slight sequential ...

Q4 2024 Management View CEO Vas Narasimhan highlighted Novartis' strong performance in Q4 2024, with sales increasing 16% and ...

Viavi Solutions expects $276 million to $288 million in Q3 FY25 revenue. The EPS guidance of $0.10 to $0.13 also beats analyst expectations.

Discretionary categories like luxury and big ticket home purchases performed disproportionately poorly as inflation remained ...

Microsoft announces Small, Medium Enterprises and Channel, SME&C, headed by President Ralph Haupter, replaced as EMEA leader ...

Live Updates Make sure to refresh this page periodically for updates. Deep Dive into ABBV's Earnings Call 01/01/1970 12:00 am ...

General Dynamics faces challenges in the aerospace and submarine segments, impacting performance, but growth expected, ...

Two years after AbbVie’s loss of market exclusivity for Humira, those “How it Started and How it’s Going” memes are looking ...

CEO Mikael Bratt highlighted a record-breaking quarter with all-time highs in operating profit, operating margin, and earnings per share, despite a 5% year-over-year decrease in sales due to currency ...

“Our record revenue and strong operating margins drove EPS to a new all-time record with double-digit growth and allowed us ...

Eastman Chemical Co. posted a nearly 2 percent increase in full-year sales, reaching just under $9.4 billion in 2024, while ...

The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...